Skip to main
MTCR
MTCR logo

Metacrine (MTCR)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Metacrine (MTCR) Stock

About Metacrine (MTCR)

Metacrine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapies for patients with liver and gastrointestinal (GI) diseases. It offers farnesoid X receptor (FXR), which is central to modulating liver and GI diseases. The company was founded by Ronald M. Evans, Richard A. Heyman, and Michael Downes in 2014 and is headquartered in San Diego, ...read more
Market cap$24.75M
Today's volume
Revenue (TTM)
Avg. daily volume59.45K
EBITDA (TTM)
Open
Price / earnings ratio-0.57x
Today's range
Debt / equity
52 week range$0.3 - $0.59
5 year debt / equity
Beta (LTM)0.02x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsNov 14, 2022
Dividend payable date

Metacrine Stock Rating

What analysts recommend for MTCR stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jul 08, 2025, the market cap for Metacrine stock is $24.75M

The current P/E ratio for Metacrine stock is -0.57

The 52-week high for Metacrine stock is $0.59. The current Metacrine stock price $undefined is 100.00% below its 52-week high

The 52-week low for Metacrine stock is $0.30. The current Metacrine stock price $undefined has increased 100.00% from its 52-week low

No, the Metacrine stock does not pay dividends to its shareholders

The target price for Metacrine stock is $14.75 based on the average of what a group of analyst think Metacrine stock could be worth at a future date. This is not a prediction by Public.com

How to buy Metacrine stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in Metacrine stock

    Navigate to the Explore page. Then, type Metacrine into the search bar. When you see Metacrine stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased Metacrine stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Metacrine Stock Earnings

The value each MTCR share was expected to gain vs. the value that each MTCR share actually gained.

Metacrine (MTCR) reported Q3 2022 earnings per share (EPS) of -$0.13, missing estimates of -$0.10 by 30.00%. In the same quarter last year, Metacrine's earnings per share (EPS) was -$0.69. Metacrine is expected to release next earnings on 11/14/2022, with an earnings per share (EPS) estimate of $0.

Buy Metacrine (MTCR) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.